Browse diseases

…p a novel in vitro system to simulate the GBA.Design We used an AD animal model to examine the spread of tau from the brain to the…

…This case highlights the rare coexistence of Wernicke’s encephalopathy, probable progressive supranuclear palsy and probable Alzheimer…

…nt of preventive measures’ can truly prevent dementia: ‘nor can dementia be ‘wiped out’ as though it is an infectious disease—aging and …

…well-being, markers of brain plasticity and blood biomarkers of Alzheimer’s disease and neurodegeneration. Tertiary objectives are to identify fact…

…uch as dementia. A large Swedish study reports that people with type 1 diabetes had double the risk of a dementia diagnosis over 14 years of fo…

…rion diseases near-perfectly and could act as a flag to suspect prion diseases.thomas.coysh@nhs.net…

…Despite recent developments in amyloid-clearing therapies for Alzheimer’s Disease (AD), there remains a need for more effective treatments. Funde…

…r’s disease (AD) versus placebo in individuals with preclinical AD and AD with MCI, the earliest stages of the pathological cascad…

…ge prospective longitudinal speech cohort including people with dementia, MND, Parkinson’s disease (PD), and progressive multiple sclero…

… 111 (25.9%) were diagnosed with possible clinical diagnosis of AD. Of these, 70 (63.1%) met cognitive criteria for DMT eligibilit…

… FDG-PET in 44.06%, and CSF analysis in 31.00% of participants. Alzheimer’s disease was the most common diagnosis (24.94%), with pathological confi…

… patient age was 60-65 years. The commonest diagnoses seen were Alzheimer’s Disease (30%), Functional memory impairment (14%) and Mild Cognitive Im…